electroCore, Inc. (ECOR) is trading up 39.61% at $2.15 per share so far Friday. ECOR stock is up sharp after announcing the availability and pricing of their gammaCore Sapphire CV for the treatment of suspected covid-19 patients with asthma-related breathing difficulties.
electroCore, Inc. (ECOR) stock is up 70.63% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary scoring system, gives ECOR stock a score of 70 out of a possible 100.
That score is mainly influenced by a fundamental score of 96. In addition to the average rating from Wall Street analysts, ECOR stock has a mean target price of 3.25. This means analysts expect the stock to rise 51.16% over the next 12 months. ECOR’s score also includes a long-term technical score of 89. The short-term technical score for ECOR is 26.
What’s Happening with ECOR Stock Today
electroCore, Inc. (ECOR) stock is trading at $2.15 as of 11:23 AM on Friday, Jul 31, an increase of $0.61, or 39.68% from the previous closing price of $1.54. The stock has traded between $2.11 and $3.00 so far today. Volume today is more active than usual. So far 47,043,798 shares have traded compared to average volume of 8,150,565 shares.